Evidence map›Paper›PMID 37550885›Full record

ArticleProtein science : a publication of the Protein Society2023

Arginine cluster introduction on framework region in anti-lysozyme antibody improved association rate constant by changing conformational diversity of CDR loops.

Shingo Maeta, Makoto Nakakido, Hiroaki Matsuura, Naoki Sakai, Kunio Hirata, Daisuke Kuroda, Atsushi Fukunaga, Kouhei Tsumoto

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shingo MaetaBio-Diagnostic Reagent Technology Center, Sysmex Corporation, Kobe, Japan.
Makoto NakakidoDepartment of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, Japan.ORCID 0000-0003-0328-9914
Hiroaki MatsuuraLife Science Research Infrastructure Group, RIKEN SPring-8 Center, Saitama, Japan.
Naoki SakaiLife Science Research Infrastructure Group, RIKEN SPring-8 Center, Saitama, Japan.
Kunio HirataLife Science Research Infrastructure Group, RIKEN SPring-8 Center, Saitama, Japan.
Daisuke KurodaDepartment of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, Japan.
Atsushi FukunagaBio-Diagnostic Reagent Technology Center, Sysmex Corporation, Kobe, Japan.
Kouhei TsumotoDepartment of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibodies are used for many therapeutic and biotechnological purposes. Because the affinity of an antibody to the antigen is critical for clinical efficacy of pharmaceuticals, many affinity maturation strategies have been developed. Although we previously reported an affinity maturation strategy in which the association rate of the antibody toward its antigen is improved by introducing a cluster of arginine residues into the framework region of the antibody, the detailed molecular mechanism responsible for this improvement has been unknown. In this study, we introduced five arginine residues into an anti-hen egg white lysozyme antibody (HyHEL10) Fab fragment to create the R5-mutant and comprehensively characterized the interaction between antibody and antigen using thermodynamic analysis, X-ray crystallography, and molecular dynamics (MD) simulations. Our results indicate that introduction of charged residues strongly enhanced the association rate, as previously reported, and the antibody-antigen complex structure was almost the same for the R5-mutant and wild-type Fabs. The MD simulations indicate that the mutation increased conformational diversity in complementarity-determining region loops and thereby enhanced the association rate. These observations provide the molecular basis of affinity maturation by R5 mutation.

Indexed as

Antigen-Antibody ComplexAntigensComplementarity Determining RegionsCrystallography, X-RayImmunoglobulin Fab FragmentsProtein ConformationAntigen-Antibody ComplexAntigensComplementarity Determining RegionsImmunoglobulin Fab Fragmentsencounter complexfabmolecular dynamics simulationSPRtransition stateX-ray crystallography

Identifiers

PMID37550885
PMCPMC10461459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.